115 related articles for article (PubMed ID: 24378440)
1. Combination of hybrid peptide with biodegradable gelatin hydrogel for controlled release and enhancement of anti-tumor activity in vivo.
Gaowa A; Horibe T; Kohno M; Sato K; Harada H; Hiraoka M; Tabata Y; Kawakami K
J Control Release; 2014 Feb; 176():1-7. PubMed ID: 24378440
[TBL] [Abstract][Full Text] [Related]
2. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel.
Konishi M; Tabata Y; Kariya M; Hosseinkhani H; Suzuki A; Fukuhara K; Mandai M; Takakura K; Fujii S
J Control Release; 2005 Mar; 103(1):7-19. PubMed ID: 15710496
[TBL] [Abstract][Full Text] [Related]
3. In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel.
Konishi M; Tabata Y; Kariya M; Suzuki A; Mandai M; Nanbu K; Takakura K; Fujii S
J Control Release; 2003 Oct; 92(3):301-13. PubMed ID: 14568411
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of anti-tumor activity of hybrid peptide in conjugation with carboxymethyl dextran via disulfide linkers.
Gaowa A; Horibe T; Kohno M; Tabata Y; Harada H; Hiraoka M; Kawakami K
Eur J Pharm Biopharm; 2015 May; 92():228-36. PubMed ID: 25801495
[TBL] [Abstract][Full Text] [Related]
5. Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels.
Matsui M; Tabata Y
Acta Biomater; 2012 May; 8(5):1792-801. PubMed ID: 22293581
[TBL] [Abstract][Full Text] [Related]
6. A cisplatin slow-release hydrogel drug delivery system based on a formulation of the macrocycle cucurbit[7]uril, gelatin and polyvinyl alcohol.
Oun R; Plumb JA; Wheate NJ
J Inorg Biochem; 2014 May; 134():100-5. PubMed ID: 24595010
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin.
Ren S; Dai Y; Li C; Qiu Z; Wang X; Tian F; Zhou S; Liu Q; Xing H; Lu Y; Chen X; Li N
Eur J Pharm Sci; 2016 Sep; 92():137-45. PubMed ID: 27388491
[TBL] [Abstract][Full Text] [Related]
8. Cationized catalase-loaded hydrogel for growth inhibition of peritoneally disseminated tumor cells.
Hyoudou K; Nishikawa M; Ikemura M; Kobayashi Y; Mendelsohn A; Miyazaki N; Tabata Y; Yamashita F; Hashida M
J Control Release; 2007 Sep; 122(2):151-8. PubMed ID: 17651858
[TBL] [Abstract][Full Text] [Related]
9. Preparation of gelatin hydrogels incorporating low-molecular-weight heparin for anti-fibrotic therapy.
Saito T; Tabata Y
Acta Biomater; 2012 Feb; 8(2):646-52. PubMed ID: 22079782
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced angiogenesis is increased by the controlled release of deferoxiamine from gelatin hydrogels.
Saito T; Tabata Y
Acta Biomater; 2014 Aug; 10(8):3641-9. PubMed ID: 24769115
[TBL] [Abstract][Full Text] [Related]
11. Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity.
Lin Z; Gao W; Hu H; Ma K; He B; Dai W; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2014 Jan; 174():161-70. PubMed ID: 24512789
[TBL] [Abstract][Full Text] [Related]
12. Preparation of gelatin hydrogels incorporating small interfering RNA for the controlled release.
Saito T; Tabata Y
J Drug Target; 2012 Dec; 20(10):864-72. PubMed ID: 23009281
[TBL] [Abstract][Full Text] [Related]
13. In vivo controlled release and prolonged antitumor effects of 2-methoxyestradiol solid lipid nanoparticles incorporated into a thermosensitive hydrogel.
Guo X; Xing Y; Zhang X; Li J; Mei Q; Zhang H; Chen C; Zhang Z; Cui F
Drug Deliv; 2012 May; 19(4):188-93. PubMed ID: 22643052
[TBL] [Abstract][Full Text] [Related]
14. Prevention of pulmonary metastasis from subcutaneous tumors by binary system-based sustained delivery of catalase.
Hyoudou K; Nishikawa M; Ikemura M; Kobayashi Y; Mendelsohn A; Miyazaki N; Tabata Y; Yamashita F; Hashida M
J Control Release; 2009 Jul; 137(2):110-5. PubMed ID: 19361547
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis.
Kimura Y; Tabata Y
J Biomater Sci Polym Ed; 2010; 21(1):37-51. PubMed ID: 20040152
[TBL] [Abstract][Full Text] [Related]
16. A micelle-shedding thermosensitive hydrogel as sustained release formulation.
de Graaf AJ; Azevedo Próspero dos Santos II; Pieters EH; Rijkers DT; van Nostrum CF; Vermonden T; Kok RJ; Hennink WE; Mastrobattista E
J Control Release; 2012 Sep; 162(3):582-90. PubMed ID: 22971272
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors.
Ding D; Zhu Z; Liu Q; Wang J; Hu Y; Jiang X; Liu B
Eur J Pharm Biopharm; 2011 Sep; 79(1):142-9. PubMed ID: 21272637
[TBL] [Abstract][Full Text] [Related]
18. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis induced by controlled release of neuropeptide substance P.
Kohara H; Tajima S; Yamamoto M; Tabata Y
Biomaterials; 2010 Nov; 31(33):8617-25. PubMed ID: 20708795
[TBL] [Abstract][Full Text] [Related]
20. A single replacement of histidine to arginine in EGFR-lytic hybrid peptide demonstrates the improved anticancer activity.
Tada N; Horibe T; Haramoto M; Ohara K; Kohno M; Kawakami K
Biochem Biophys Res Commun; 2011 Apr; 407(2):383-8. PubMed ID: 21396910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
